Harvard Bioscience Inc (HBIO) Stock Price

HBIOStock
$8.09+102.25%52W
Market Cap$36.83M
P/E—
PEG Ratio1.31
Div yield—
Beta1.48

HBIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)54.86%
Price vs S&P 500 (4W)2.45%
PEG Ratio1.31
VGM Score57.45

HBIO Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$0.21-$0.14+33.33%(+$0.07)
Q4 2025$0.35$0.00-100.00%(-$0.35)
Q3 2025$0.05$0.00-100.00%(-$0.05)
Q2 2025-$0.25-$0.10+60.00%(+$0.15)

HBIO Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.00
4.00
4.00

Industry Peers — Lab Analytical Instruments(25)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
HBIOHarvard Bioscience Inc
CDA0.4x-3.3%58.2%-1.7%$8.09
AAgilent Technologies Inc.DCA6.6x5.4%53.9%22.2%$172.97
WATWaters CorpFCA9.4x6.0%50.9%7.1%$436.95
ILMNIllumina IncDDA8.8x6.0%66.4%19.5%$262.54
MTDMettler-Toledo InternationalDCA7.9x5.5%60.3%26.6%$1622.29
RVTYRevvity, Inc.DDA5.8x-5.5%55.0%12.3%$152.64
AVTRAvantor, Inc.CFA1.7x0.5%31.8%-4.7%$16.42
BIO.BBio-Rad Laboratories, Inc. Class BCDB3.7x0.3%51.9%1.8%$364.15
BIOBio-Rad Laboratories, Inc.Class ACDB3.7x0.3%51.9%1.8%$353.70
TXG10x Genomics, Inc. Class A Common StockFDA14.8x16.6%69.6%-14.3%$69.86
BRKRBruker CorporationDDB2.4x11.6%47.7%-1.5%$54.80

About Harvard Bioscience Inc

Harvard Bioscience designs and manufactures specialized instruments and products for life sciences research, pharmaceutical discovery, and drug development. The company serves customers globally through direct and distribution channels, with brands including Harvard Apparatus, DSI, Buxco, Biochrom, and others. Most revenue is generated in the United States, though the company maintains operations across North America, Europe, and China.